keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MT-802 is an effective BTK degrader based on PROTAC technology (DC50: 1 nM). MT-802 has the potential to treat C481S mutant chronic lymphocytic leukemia (CLL).
説明 | MT-802 is an effective BTK degrader based on PROTAC technology (DC50: 1 nM). MT-802 has the potential to treat C481S mutant chronic lymphocytic leukemia (CLL). |
ターゲット&IC50 | BTK:1 nM(DC50) |
In vitro | MT-802 degrades BTK (DC50: 9.1 nM). The maximal degradation was observed by 250 nM. |
分子量 | 787.82 |
分子式 | C41H41N9O8 |
CAS No. | 2231744-29-7 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (126.93 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MT-802 2231744-29-7 Angiogenesis PROTAC Tyrosine Kinase/Adaptors BTK PROTACs inhibit MT802 Inhibitor Btk Bruton tyrosine kinase MT 802 inhibitor